Education
About Us
Working with TipRanks
Follow Us
AFT Pharmaceuticals Ltd. (AU:AFP)
ASX:AFP
AFP Stock Chart & Stats
AU$3.12
-AU$0.03(-1.16%)
At close: 4:00 PM EST
AU$3.12
-AU$0.03(-1.16%)
Day’s Range― - ―
52-Week RangeAU$2.10 - AU$3.35
Previous CloseN/A
Volume204.00
Average Volume (3M)2.52K
Market Cap
AU$327.36M
Enterprise ValueAU$272.86M
Total Cash (Recent Filing)AU$11.11M
Total Debt (Recent Filing)AU$30.00M
Price to Earnings (P/E)20.7
Beta-0.29
Next Earnings
May 25, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend Yield0.53%
Share Statistics
EPS (TTM)0.03
Shares Outstanding104,866,260
10 Day Avg. Volume3,466
30 Day Avg. Volume2,523
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)0.00
Price to Sales (P/S)0.00
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusHold
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
AFT Pharmaceuticals Ltd. News
AFP FAQ
What was AFT Pharmaceuticals Ltd.’s price range in the past 12 months?
AFT Pharmaceuticals Ltd. lowest share price was AU$2.10 and its highest was AU$3.35 in the past 12 months.
What is AFT Pharmaceuticals Ltd.’s market cap?
AFT Pharmaceuticals Ltd.’s market cap is AU$327.36M.
When is AFT Pharmaceuticals Ltd.’s upcoming earnings report date?
AFT Pharmaceuticals Ltd.’s upcoming earnings report date is May 25, 2026 which is in 159 days.
How were AFT Pharmaceuticals Ltd.’s earnings last quarter?
AFT Pharmaceuticals Ltd. released its earnings results on Nov 19, 2025. The company reported AU$0.026 earnings per share for the quarter, beating the consensus estimate of N/A by AU$0.026.
Is AFT Pharmaceuticals Ltd. overvalued?
According to Wall Street analysts AFT Pharmaceuticals Ltd.’s price is currently Overvalued.
Does AFT Pharmaceuticals Ltd. pay dividends?
AFT Pharmaceuticals Ltd. pays a Annually dividend of AU$0.017 which represents an annual dividend yield of 0.53%. See more information on AFT Pharmaceuticals Ltd. dividends here
What is AFT Pharmaceuticals Ltd.’s EPS estimate?
AFT Pharmaceuticals Ltd.’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does AFT Pharmaceuticals Ltd. have?
AFT Pharmaceuticals Ltd. has 104,866,260 shares outstanding.
What happened to AFT Pharmaceuticals Ltd.’s price movement after its last earnings report?
AFT Pharmaceuticals Ltd. reported an EPS of AU$0.026 in its last earnings report, beating expectations of N/A. Following the earnings report the stock price went up 1.107%.
Which hedge fund is a major shareholder of AFT Pharmaceuticals Ltd.?
Currently, no hedge funds are holding shares in AU:AFP
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
AFT Pharmaceuticals Ltd.
AFT Pharmaceuticals Limited develops, licenses, distributes, and sells pharmaceutical products in New Zealand, Australia, Asia, and internationally. It offers products for use in the areas of allergy, cold and flu, eyecare, first aid, pain management, gastrointestinal, dermatology, and medicated vitamins. The company was incorporated in 1997 and is headquartered in Auckland, New Zealand.
Technical Analysis
Options Prices
Currently, No data available
---